Elations offers joint health aid in powder form
CINCINNATI Elations now offers their patent-pending formula in a powder form for improving joint health, the company announced.
The new powder packets deliver the same recommended levels of glucosamine and chondroitin as the original Elations drink supplement.
Consumer testing showed that 75% of the general population strongly agrees that powder would be good to use on the go and that it’s more absorbable and easier to swallow than pills.
The new Elations powder pack, shipping in February, will be available in two-flavors — cranberry-apple and raspberry white grape. To use, empty contents of one packet into a 20-ounce bottle of water, then shake or mix well. Suggested retail price for the 7-stick box ranges from $6.97 – $7.99.
Elations also introduced a new flavor to its ready-to-drink line — black cherry.
Nutrition 21 completes sale of direct response, retail businesses to Nature’s Products
PURCHASE, N.Y. Nutrition 21 on Tuesday announced that it has sold substantially all of the assets of its direct response and retail businesses to Nature’s Products, based in Sunrise, Fla. The purchase price was approximately $3.2 million, plus the assumption of designated liabilities.
“We entered into this transaction to focus our limited financial resources on our profitable ingredients business,” stated Michael Zeher, Nutrition 21 president and CEO.
Continua Health Alliance develops first end-to-end connected health solution
BEAVERTON, Ore. Wireless management of such health devices as blood glucose meters and blood pressure monitors took one step closer to becoming reality Monday with the Continua Health Alliance announcement of the first end-to-end connected health solution based on the Continua architecture.
IBM, Nonin Medical, and Vignet will demonstrate the end-to-end solution this week at the Consumer Electronics Show, and illustrate how data from consumer health devices can be transmitted to a variety of destinations, including hospitals, medical offices and patient information systems.
In the demonstration, data from a Continua Certified Bluetooth-enabled wireless pulse oximeter from Nonin Medical will be sent to a P.C. manager running the Vignet Connected Health Services platform using the Continua device interface standard. The manager will upload the data to an IBM server using the Continua WAN interface standard. From there, the IBM server can send the data, using the Continua interface, to various service providers such as healthcare facilities, disease management services or personal health record services.
“IBM is committed to enabling connected home health solutions such as remote patient monitoring, which have great potential to improve patient outcomes and deliver more affordable health care,” stated Katherine Holland, GM for IBM Global Life Sciences. “Demonstrating an end-to-end implementation of the Continua architecture is an important milestone, and IBM is pleased to partner with Continua members to build an ecosystem of interoperable, personal connected health solutions.”
The publication of the Continua Health Alliance Version One Design Guidelines last year paved the way for Continua members to develop compliant connected health products and services. The Continua interoperability guidelines specify how to use existing standards to build interoperable personal healthcare solutions. The group’s next design guidelines, expected in the first half of 2010, will include two wireless technology standards for low power radios and will enable new devices, additional use cases and extend the capabilities of devices in the Continua Health Alliance ecosystem.